Anti-inflammatory medicinal plants may have a pleiotropic role in COVID-19 treatment, as elevated levels of inflammatory markers such as interleukin (IL)-6, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) have been linked to severe disease and poor outcomes in COVID-19 patients, most likely due to cytokine storm (61). This evidence concerns the gene IL6 and COVID-19.